78 results
8-K
EX-99.2
MDGL
Madrigal Pharmaceuticals Inc
14 Mar 24
Regulation FD Disclosure
6:47pm
/GI targets ~6K top treaters Market Access Patient Support â–ª 15 yrs. experience â–ª 18 yrs. experience â–ª Best-in-class HEOR data â–ª Expert support
8-K
MDGL
Madrigal Pharmaceuticals Inc
28 Feb 24
Departure of Directors or Certain Officers
7:10am
% of her base salary, based on the achievement of corporate and individual targets determined by the Compensation Committee of the Company’s Board
8-K
EX-10.1
lspn ncpfp2
13 Sep 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
l324772txo4u4mkn 9ip
4 Aug 22
Madrigal Pharmaceuticals Provides Clinical and Business Updates and Reports 2022 Second Quarter Financial Results
6:33am
8-K
EX-99.1
p5mm7
9 May 22
Madrigal Pharmaceuticals Provides Clinical and Business Updates and Reports 2022 First Quarter Financial Results
6:33am
8-K
EX-99.1
yxwu7e
4 Nov 21
Madrigal Pharmaceuticals Provides Corporate Update and Reports 2021 Third Quarter Financial Results
8:30am
8-K
EX-99.1
86oss23 q75p
5 Aug 21
Madrigal Pharmaceuticals Reports 2021 Second Quarter Financial Results and Provides Corporate Update
8:31am
424B5
zelh03mix
20 Dec 17
Prospectus supplement for primary offering
12:00am